Skip to main content
Log in

Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Backgrounds

Gamma-glutamyltransferase (GGT) is an enzyme responsible for the extracellular catabolism of the antioxidant glutathione and recently implicated in the pathogenesis of atherosclerosis. Endothelial dysfunction is a prodromal feature of atherogenesis. Since oxidative stress is highly present in uremia and causally linked to endothelial dysfunction, we hypothesized that GGT may be a factor implicated in this process.

Methods

Serum GGT and C-reactive protein (CRP) levels, estimated glomerular filtration rate (eGFR), and 24-h proteinuria were measured in 214 nondiabetic stages 3–5 CKD patients. The endothelium-dependent vasodilatation (FMD) of the brachial artery was assessed by using high-resolution ultrasound. We investigated the relationship between FMD and circulating serum GGT.

Results

Serum GGT levels were negatively associated with FMD (r = −0.41, p < 0.001) and eGFR (r = −0.34, p < 0.001) in univariate analysis. Multivariate regression analysis showed that the association between GGT and FMD persisted after adjustment for age, sex, smoking, renal function (eGFR), inflammation (CRP), proteinuria, and homeostatic model assessment index.

Conclusion

Circulating GGT levels significantly associate with endothelial dysfunction, an important early feature of the atherogenic process. GGT might be an early marker of oxidative or other cellular stress that it is possibly directly related to the pathogenesis of endothelial dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX (2006) Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17:2034–2047

    Article  PubMed  Google Scholar 

  2. Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126

    Article  PubMed  CAS  Google Scholar 

  3. Yilmaz MI, Saglam M, Caglar K, Cakir E, Sonmez A, Ozgurtas T, Aydin A, Eyileten T, Ozcan O, Acikel C, Tasar M, Genctoy G, Erbil K, Vural A, Zoccali C (2006) The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 47:42–50

    Article  PubMed  CAS  Google Scholar 

  4. Sahin EBF, Karaman M, Ay AS, Saglam M, Cakir E, Yilmaz MI (2010) The relationship between endothelial dysfunction and pentraxin-3 concentration in chronic kidney disease. Turk Nephrol Dial Transpl 19:192–198

    Article  Google Scholar 

  5. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G (2001) Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104:191–196

    Article  PubMed  CAS  Google Scholar 

  6. Zoccali C (2006) Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension. J Am Soc Nephrol 17(Suppl 2):S61–S63

    Article  PubMed  Google Scholar 

  7. Whitfield JB (2001) Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38:263–355

    Article  PubMed  CAS  Google Scholar 

  8. Drozdz R, Parmentier C, Hachad H, Leroy P, Siest G, Wellman M (1998) Gamma-glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med 25:786–792

    Article  PubMed  CAS  Google Scholar 

  9. Dominici S, Valentini M, Maellaro E, Del Bello B, Paolicchi A, Lorenzini E, Tongiani R, Comporti M, Pompella A (1999) Redox modulation of cell surface protein thiols in U937 lymphoma cells: the role of gamma-glutamyl transpeptidase-dependent H2O2 production and S-thiolation. Free Radic Biol Med 27:623–635

    Article  PubMed  CAS  Google Scholar 

  10. Lee DH, Blomhoff R, Jacobs DR (2004) Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 38:535–539

    Article  PubMed  CAS  Google Scholar 

  11. Caliskan M, Erdogan D, Gullu H, Ciftci O, Yildirim I, Baycan S, Yildirir A, Muderrisoglu H (2007) Association between serum gamma-glutamyltransferase levels and coronary microvascular function in hypertensive patients. J Hypertens 25:2497–2503

    Article  PubMed  CAS  Google Scholar 

  12. Caliskan M, Erdogan D, Gullu H, Muderrisoglu H (2008) Higher serum gamma-glutamyltransferase levels are independently associated with impaired coronary microvascular function in patients with dilated cardiomyopathy. Atherosclerosis 201:163–167

    Article  PubMed  CAS  Google Scholar 

  13. Emdin M, Pompella A, Paolicchi A (2005) Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 112:2078–2080

    Article  PubMed  Google Scholar 

  14. Emdin M, Passino C, Michelassi C, Titta F, L’abbate A, Donato L, Pompella A, Paolicchi A (2001) Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J 22:1802–1807

    Article  PubMed  CAS  Google Scholar 

  15. Meisinger C, Döring A, Schneider A, Löwel H, Group KS (2006) Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 189:297–302

    Article  PubMed  CAS  Google Scholar 

  16. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H (2005) Group VHMaPPS. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 112:2130–2137

    Article  PubMed  CAS  Google Scholar 

  17. Lee DH, Silventoinen K, Hu G, Jacobs DR, Jousilahti P, Sundvall J, Tuomilehto J (2006) Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J 27:2170–2176

    Article  PubMed  CAS  Google Scholar 

  18. Perry IJ, Wannamethee SG, Shaper AG (1998) Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 21:732–737

    Article  PubMed  CAS  Google Scholar 

  19. Lee DH, Jacobs DR, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M (2003) Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 49:1358–1366

    Article  PubMed  CAS  Google Scholar 

  20. Wannamethee SG, Shaper AG, Lennon L, Whincup PH (2005) Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 28:2913–2918

    Article  PubMed  CAS  Google Scholar 

  21. Lee DH, Jacobs DR, Gross M, Steffes M (2005) Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 51:1185–1191

    Article  PubMed  CAS  Google Scholar 

  22. Ryu S, Chang Y, Kim DI, Kim WS, Suh BS (2007) Gamma-glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem 53:71–77

    Article  PubMed  CAS  Google Scholar 

  23. Targher G, Chonchol M, Bertolini L, Rodella S, Zenari L, Lippi G, Franchini M, Zoppini G, Muggeo M (2008) Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol 19:1564–1570

    Article  PubMed  CAS  Google Scholar 

  24. Postorino M, Marino C, Tripepi G, Zoccali C (2008) Gammaglutamyltransferase in ESRD as a predictor of all-cause and cardiovascular mortality: another facet of oxidative stress burden. Kidney Int Suppl 111:S64–S66

    Article  PubMed  CAS  Google Scholar 

  25. Targher G (2010) Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer—a narrative review. Clin Chem Lab Med 48:147–157

    Article  PubMed  CAS  Google Scholar 

  26. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM (2002) The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62:1524–1538

    Article  PubMed  CAS  Google Scholar 

  27. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470

    Article  PubMed  CAS  Google Scholar 

  28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419

    Article  PubMed  CAS  Google Scholar 

  29. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111–1115

    Article  PubMed  CAS  Google Scholar 

  30. Franzini M, Corti A, Martinelli B, Del Corso A, Emdin M, Parenti GF, Glauber M, Pompella A, Paolicchi A (2009) Gamma-glutamyltransferase activity in human atherosclerotic plaques–biochemical similarities with the circulating enzyme. Atherosclerosis 202:119–127

    Article  PubMed  CAS  Google Scholar 

  31. Paolicchi A, Emdin M, Passino C, Lorenzini E, Titta F, Marchi S, Malvaldi G, Pompella A (2006) Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis 186:80–85

    Article  PubMed  CAS  Google Scholar 

  32. Turgut O, Yilmaz A, Yalta K, Karadas F, Birhan Yilmaz M (2006) Gamma-glutamyltransferase is a promising biomarker for cardiovascular risk. Med Hypotheses 67:1060–1064

    Article  PubMed  CAS  Google Scholar 

  33. Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA (2009) Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women’s Heart and Health Study and meta-analysis. Diabetes Care 32:741–750

    Article  PubMed  CAS  Google Scholar 

  34. Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA (2007) Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women’s Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol 27:2729–2735

    Article  PubMed  CAS  Google Scholar 

  35. Lee DH, Steffes MW, Jacobs DR (2008) Can persistent organic pollutants explain the association between serum gamma-glutamyltransferase and type 2 diabetes? Diabetologia 51:402–407

    Article  PubMed  CAS  Google Scholar 

  36. Lee DH, Jacobs DR (2009) Is serum gamma-glutamyltransferase a marker of exposure to various environmental pollutants? Free Radic Res 43:533–537

    Article  PubMed  CAS  Google Scholar 

  37. Daeppen JB, Smith TL, Schuckit MA (1998) Influence of age and body mass index on gamma-glutamyltransferase activity: a 15-year follow-up evaluation in a community sample. Alcohol Clin Exp Res 22:941–944

    PubMed  CAS  Google Scholar 

  38. Nilssen O, Førde OH, Brenn T (1990) The Tromsø Study. Distribution and population determinants of gamma-glutamyltransferase. Am J Epidemiol 132:318–326

    PubMed  CAS  Google Scholar 

  39. Diercks GF, van Boven AJ, Hillege JL, de Jong PE, Rouleau JL, van Gilst WH (2002) The importance of microalbuminuria as a cardiovascular risk indicator: a review. Can J Cardiol 18:525–535

    PubMed  CAS  Google Scholar 

  40. Franzini M, Ottaviano V, Fierabracci V, Bramanti E, Zyw L, Barsacchi R, Scatena F, Boni C, Mammini C, Passino C, Pompella A, Emdin M, Paolicchi A (2008) Fractions of plasma gamma-glutamyltransferase in healthy individuals: reference values. Clin Chim Acta 395:188–189

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank the patients and personnel involved in the creation of this patient material. The authors would like to express their sincere appreciation to FAVOR (FMF Arthritis Vasculitis and Orphan Diseases Research/www.favor.org.tr) web registries at Gulhane Military Medical Academy, Institute of Health Sciences for their supports in epidemiological and statistical advisory and invaluable guidance for the preparation of the manuscript. We acknowledge support from the Gülhane School of Medicine in Turkey, the Swedish Research Council, and the Loo and Hans Osterman Foundation.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehmet Kanbay.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yilmaz, M.I., Turgut, F., Kanbay, M. et al. Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease. Int Urol Nephrol 45, 1071–1078 (2013). https://doi.org/10.1007/s11255-012-0354-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-012-0354-2

Keywords

Navigation